Showing 1 - 3 results of 3 for search 'Sarah L Henkle', query time: 0.02s Refine Results
  1. 1
    Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.

    Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis. by Ruth S Waterman, Sarah L Henkle, Aline M Betancourt

    Published 2012-01-01
    Get full text
    Article
  2. 2
    A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

    A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. by Ruth S Waterman, Suzanne L Tomchuck, Sarah L Henkle, Aline M Betancourt

    Published 2010-04-01
    Get full text
    Article
  3. 3
    Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells.

    Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells. by Suzanne L Tomchuck, Sarah L Henkle, Seth B Coffelt, Aline M Betancourt

    Published 2012-01-01
    Get full text
    Article

Search Tools: